PTI.The ICMR has selected 12 institutes to conduct these trials, including AIIMS in Delhi and Patna. The apex medical body asked their principal investigators to ensure the enrolment process is initiated no later than by July 7."Everything will be sent to ICMR, where data is analysed.
We have already started the screening of individuals. We will first take audio visual consent of the individual," the doctor added.For clinical human trial in Hyderabad's Nizams Institute of Medical Sciences, at least 30 people are required, said the medical officer.Last week, the Drug Controller General of India recently granted permission to initiate Phase I & II human clinical trials for COVID-19 Vaccine Covaxin.